These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35438827)

  • 1. Monitoring of heparin therapy beyond the anti-Xa activity assay: Evaluation of a thrombin generation assay.
    Vermeiren P; Vandevelde A; Peperstraete H; Devreese KMJ
    Int J Lab Hematol; 2022 Aug; 44(4):785-795. PubMed ID: 35438827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Heparin Monitoring with the Anti-Xa Assay.
    Dean CL
    Methods Mol Biol; 2023; 2663():343-353. PubMed ID: 37204722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay.
    Billoir P; Elie T; Levy JH; Besnier E; Dureuil B; Veber B; Le Cam-Duchez V; Clavier T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months.
    Foulon-Pinto G; Jourdi G; Perrin J; Abdoul J; Paris G; Gouin-Thibault I; Curis E; Lecompte T; Siguret V
    Int J Lab Hematol; 2021 Aug; 43(4):821-830. PubMed ID: 33369212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of in vitro thrombin generation after neutralization of heparin.
    Hardy M; Douxfils J; Morimont L; Didembourg M; Carlo A; de Maistre E; Lecompte T; Mullier F
    Int J Lab Hematol; 2022 Feb; 44(1):168-176. PubMed ID: 34582127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation assay identifies individual variability in responses to low molecular weight heparin in pregnancy: implications for anticoagulant monitoring.
    Chowdary P; Adamidou D; Riddell A; Aghighi S; Griffioen A; Priest P; Moghadam L; Kelaher N; Huq FY; Kadir RA; Tuddenham EG; Gatt A
    Br J Haematol; 2015 Mar; 168(5):719-27. PubMed ID: 25351814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V; Summerhayes R; Gan A; Than J; Chan A; Cochrane A; Bennett M; Horton S; Shann F; Lane G; Ross-Smith M; Monagle P
    Thromb Res; 2007; 120(3):347-51. PubMed ID: 17118432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.
    Cosmi B; Fredenburgh JC; Rischke J; Hirsh J; Young E; Weitz JI
    Circulation; 1997 Jan; 95(1):118-24. PubMed ID: 8994426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated Thrombogram.
    Helin TA; Lemponen M; Lassila R; Joutsi-Korhonen L
    Res Pract Thromb Haemost; 2021 Mar; 5(3):439-446. PubMed ID: 33870029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma.
    Brooks MB
    Vet Clin Pathol; 2004; 33(4):208-14. PubMed ID: 15570557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222.
    Tew CJ; Lane DA; Thompson E; Ireland H; Curtis JR
    Br J Haematol; 1988 Nov; 70(3):335-40. PubMed ID: 2849981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can an anti-Xa assay for unfractionated heparin be used to assess the presence of rivaroxaban in critical situations?
    Shin H; Koh EH; Lee GW; Song HN; Kim HY; Park S
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):741-747. PubMed ID: 32113855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays.
    Thomas O; Lybeck E; Strandberg K; Tynngård N; Schött U
    PLoS One; 2015; 10(1):e0116835. PubMed ID: 25625201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring therapeutic anticoagulation with low molecular weight heparins: is it useful or misleading?
    Hammerstingl C
    Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):282-6. PubMed ID: 18855641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of heparin calibrated anti-Xa assay for apixaban and rivaroxaban measurement in the context of regional telestroke activity].
    Delassasseigne C; Leroux C; Renou P; Girard D; Lafargue A; Morel S; Belotti PT; Weinmann L
    Ann Biol Clin (Paris); 2023 Jul; 81(3):269-279. PubMed ID: 37329142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J; Raschke R
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.
    Pfrepper C; Metze M; Siegemund A; Klöter T; Siegemund T; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):619-627. PubMed ID: 32548561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation.
    Volovyk Z; Monroe DM; Qi Y; Becker R; Hoffman M
    J Thromb Thrombolysis; 2009 Aug; 28(2):132-9. PubMed ID: 19543696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.